The context: why international cooperation? International Collaboration in FP7 - Health HEALTH is a political priority for most countries in the world; industrialised, emerging economies and low income countries Infectious diseases do not respect bor<strong>de</strong>rs and can spread worldwi<strong>de</strong> “Rich world” diseases (cancer, diabetes…) also affect the <strong>de</strong>veloping countries and vice versa (Aids, TB…) Treatments and cures are universal 12
across bor<strong>de</strong>rs and other barriers between countries: Collaborative research At least 3 partners from the 27 EU Member States: Austria, Belgium, Bulgaria, Czech Rep., Cyprus, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Swe<strong>de</strong>n, the United Kingdom. or the 13 Associated Countries: Albania, Bosnia-Herzegovina, Croatia, FYROM, Iceland, Israel, Liechtenstein, Montenegro, Norway, Serbia, Switzerland, Turkey and the Faroe Islands. In addition, researchers from anywhere in the world can participate: e.g.: Australia, Brazil, Canada, China, Egypt, India, Japan, Korea, Russia, South-Africa, USA, … and in many cases, can be fun<strong>de</strong>d. Based on draft Orientation paper – please refer to final published Work Programme 2012 13